Sfoglia per Autore
Response to bortezomib and activation of osteoblasts in multiple myeloma
2006-01-01 ZANGARI M ;YACCOBY S ;CAVALLO F ;ESSELTINE D ;TRICOT G
Farnesyltransferase inhibitors and rapamycinin the treatment of multiple myeloma
2006-01-01 Zangari M; Cavallo F; Tricot G
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
2006-01-01 HANAMURA I; STEWART JP; HUANG Y; ZHAN F; SANTRA M; SAWYER JR; HOLLMIG K; ZANGARI M; PINEDA-ROMAN M; VAN RHEE F; CAVALLO F; BURINGTON B; CROWLEY J; TRICOT; G; BARLOGIE B; SHAUGHNESSY JD JR
Targeting signaling pathways in multiple myeloma
2006-01-01 Cavallo F; Palumbo A; Tricot G; Boccadoro M
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide
2006-01-01 Musto P; Falcone A; Sanpaolo G; Guglielmelli T; Zambello R; Balleari E; Catalano L; Spriano M; Cavallo F; Sala AL; Mantuano S; Nobile M; Melillo L; Scalzulli PR; Dell'olio M; Bodenizza C; Greco MM; Carella AM Jr; Merla E; Carella AM; Boccadoro M; Cascavilla N; Palumbo A
MULTIPLE MYELOMA: CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE
2007-01-01 Omedè P; Ruggeri M; Brunetti M; Caltagirone S; Bringhen S; Cavallo F; Gilestro M; Ferro F; Spagnolo M; Di Bello C; Fantauzzo A; Bruno B; Palumbo A; Petrucci MT; Liberati AM; Boccadoro M
Review of thalidomide in the treatment of newly diagnosed multiple myeloma
2007-01-01 Cavallo F; Boccadoro M; Palumbo A.
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients.
2007-01-01 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA
2007-01-01 P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Leberati; M. Boccadoro
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA
2007-01-01 P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Liberati; M. Boccadoro
Hyperammonemia and encephalopathy in patients with multiple myeloma
2007-01-01 TALAMO G; CAVALLO F; ZANGARI M; BARLOGIE B; LEE CK; PINEDA-ROMAN M; KIWAN E; KRISHNA S; TRICOT G
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients
2007-01-01 ZANGARI M; ESSELTINE D; CAVALLO F; NEUWIRTH R; ELICE F; BURNS MJ; YACCOBY S; RICHARDSON P; SONNEVELD P; TRICOT G
Bortezomib, melphalan, prednisone and thalidomide for relapsed multiple myeloma
2007-01-01 PALUMBO A; AMBROSINI MT; BENEVOLO G; PREGNO P; PESCOSTA N; CALLEA V; CANGIALOSI C; CARAVITA T; MORABITO F; MUSTO P; BRINGHEN S; FALCO P; AVONTO I; CAVALLO F; BOCCADORO M
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy
2007-01-01 PALUMBO A; BRINGHEN S; FALCO P; CAVALLO F; AMBROSINI MT; AVONTO I; GAY F; CARAVITA T; BRUNO B; BOCCADORO M
Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients
2007-01-01 ZANGARI M; BARLOGIE B; CAVALLO F; BOLEJACK V; FINK L; TRICOT G
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients
2007-01-01 Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo
The treatment of the elderly multiple myeloma patients
2007-01-01 CAVALLO F; AMBROSINI MT; RUS C; BOCCADORO M; PALUMBO A
The hemostatic system and malignancy
2008-01-01 Adcock DM; Fink LM; Marlar RA; Cavallo F; Zangari M
Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma
2008-01-01 Zangari M; Guerrero J; Cavallo F; Prasad HK; Esseltine D; Fink L
Oral melphalan, prednisone,and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
2008-01-01 Palumbo A; Bringhen S; Liberati AM; Caravita T; Falcone A; Callea V; Montanaro M; Ria R; Capaldi A; Zambello R; Benevolo G; Derudas D; Dore F; Cavallo F; Gay F; Falco P; Ciccone G; Musto P; Cavo M; Boccadoro M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Response to bortezomib and activation of osteoblasts in multiple myeloma | 2006 | ZANGARI M ;YACCOBY S ;CAVALLO F ;ESSELTINE D ;TRICOT G | |
Farnesyltransferase inhibitors and rapamycinin the treatment of multiple myeloma | 2006 | Zangari M; Cavallo F; Tricot G | |
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation | 2006 | HANAMURA I; STEWART JP; HUANG Y; ZHAN F; SANTRA M; SAWYER JR; HOLLMIG K; ZANGARI M; PINEDA-ROMAN M; VAN RHEE F; CAVALLO F; BURINGTON B; CROWLEY J; TRICOT; G; BARLOGIE B; SHAUGHNESSY JD JR | |
Targeting signaling pathways in multiple myeloma | 2006 | Cavallo F; Palumbo A; Tricot G; Boccadoro M | |
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide | 2006 | Musto P; Falcone A; Sanpaolo G; Guglielmelli T; Zambello R; Balleari E; Catalano L; Spriano M; Cavallo F; Sala AL; Mantuano S; Nobile M; Melillo L; Scalzulli PR; Dell'olio M; Bodenizza C; Greco MM; Carella AM Jr; Merla E; Carella AM; Boccadoro M; Cascavilla N; Palumbo A | |
MULTIPLE MYELOMA: CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE | 2007 | Omedè P; Ruggeri M; Brunetti M; Caltagirone S; Bringhen S; Cavallo F; Gilestro M; Ferro F; Spagnolo M; Di Bello C; Fantauzzo A; Bruno B; Palumbo A; Petrucci MT; Liberati AM; Boccadoro M | |
Review of thalidomide in the treatment of newly diagnosed multiple myeloma | 2007 | Cavallo F; Boccadoro M; Palumbo A. | |
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. | 2007 | Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M | |
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA | 2007 | P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Leberati; M. Boccadoro | |
CHROMOSOMAL ABNORMALITIES OF PLASMA CELLS AND CORRELATION WITH IMMUNOPHENOTYPE IN MULTIPLE MYELOMA | 2007 | P. Omede; M. Ruggeri; M. Brunetti; S. Caltagirone; S. Bringhen; F. Cavallo; M. Gilestro; F. Ferro; M. Spagnolo; C. Di Bello; A. Fantauzzo; B. Bruno; A. Palumbo; M.T. Petrucci; A.M. Liberati; M. Boccadoro | |
Hyperammonemia and encephalopathy in patients with multiple myeloma | 2007 | TALAMO G; CAVALLO F; ZANGARI M; BARLOGIE B; LEE CK; PINEDA-ROMAN M; KIWAN E; KRISHNA S; TRICOT G | |
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients | 2007 | ZANGARI M; ESSELTINE D; CAVALLO F; NEUWIRTH R; ELICE F; BURNS MJ; YACCOBY S; RICHARDSON P; SONNEVELD P; TRICOT G | |
Bortezomib, melphalan, prednisone and thalidomide for relapsed multiple myeloma | 2007 | PALUMBO A; AMBROSINI MT; BENEVOLO G; PREGNO P; PESCOSTA N; CALLEA V; CANGIALOSI C; CARAVITA T; MORABITO F; MUSTO P; BRINGHEN S; FALCO P; AVONTO I; CAVALLO F; BOCCADORO M | |
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy | 2007 | PALUMBO A; BRINGHEN S; FALCO P; CAVALLO F; AMBROSINI MT; AVONTO I; GAY F; CARAVITA T; BRUNO B; BOCCADORO M | |
Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients | 2007 | ZANGARI M; BARLOGIE B; CAVALLO F; BOLEJACK V; FINK L; TRICOT G | |
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients | 2007 | Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo | |
The treatment of the elderly multiple myeloma patients | 2007 | CAVALLO F; AMBROSINI MT; RUS C; BOCCADORO M; PALUMBO A | |
The hemostatic system and malignancy | 2008 | Adcock DM; Fink LM; Marlar RA; Cavallo F; Zangari M | |
Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma | 2008 | Zangari M; Guerrero J; Cavallo F; Prasad HK; Esseltine D; Fink L | |
Oral melphalan, prednisone,and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial | 2008 | Palumbo A; Bringhen S; Liberati AM; Caravita T; Falcone A; Callea V; Montanaro M; Ria R; Capaldi A; Zambello R; Benevolo G; Derudas D; Dore F; Cavallo F; Gay F; Falco P; Ciccone G; Musto P; Cavo M; Boccadoro M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile